Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Mundipharma Research GmbH & Co KG |
---|---|
Information provided by: | Mundipharma Research GmbH & Co KG |
ClinicalTrials.gov Identifier: | NCT00412100 |
The primary objective is to demonstrate that patients taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.
Condition | Intervention | Phase |
---|---|---|
Pain |
Drug: Oxycodone naloxone prolonged release tablets (OXN) |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomsied, Double-Blind, Double-Dummy, Parallel-Group Multicentre Study to Demonstrate Improvement in Symptoms of Constipation in Subjects With Non-Malignant Pain Taking Oxycodone Equivalent of 60-80 mg/Day as Oxycodone/Naloxone Prolonged Release Compared to Subjects Taking Oxycodone Prolonged Release Tablets Alone |
Study Start Date: | April 2006 |
Estimated Study Completion Date: | July 2008 |
Patients with a documented history of moderate to severe non-malignant pain that require around-the-clock opioid therapy will be randomised to an oxycodone or an oxycodone-naloxone treatment arm. The primary objective is to demonstrate that patients taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 2005-003510-15, OXN3006 |
Study First Received: | December 14, 2006 |
Last Updated: | April 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00412100 History of Changes |
Health Authority: | Germany: Ethics Commission |
A randomised double-blind double-dummy parallel-group multicentre study to demonstrate improvement in symptoms of constipation Moderate to severe, chronic non-malignant pain |
Signs and Symptoms Signs and Symptoms, Digestive Narcotic Antagonists Oxycodone Constipation Central Nervous System Depressants |
Narcotics Pain Analgesics Peripheral Nervous System Agents Analgesics, Opioid Naloxone |
Signs and Symptoms, Digestive Oxycodone Narcotic Antagonists Physiological Effects of Drugs Central Nervous System Depressants Narcotics Pharmacologic Actions Naloxone |
Signs and Symptoms Sensory System Agents Therapeutic Uses Constipation Analgesics Peripheral Nervous System Agents Central Nervous System Agents Analgesics, Opioid |